$12.07 0.04 (+0.33%)
11/6/2009 4:00 PM

Amylin Pharmaceuticals, Inc. (AMLN)

CAPS Rating: 4 out of 5

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

Current Price $12.07 Mkt Cap $1.7B
Open $11.90 P/E Ratio 0.00
Prev. Close $12.03 Div. (Yield) N/A (N/A)
Daily Range $11.90 - $12.12 Volume 1,871,057
52-Wk Range $5.50 - $15.69 Avg. Daily Vol. 3,280,000

AMLN News and Commentary

View All AMLN News and Commentary

Caps

How do you think AMLN will perform vs the S&P 500?

Add Stock to Watchlist

All Members

348 Outperform
50 Underperform
 

All-Star Members

100 Outperform
15 Underperform
 

Wall Street

5 Outperform
5 Underperform
 

Top AMLN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

EmmyKaye (87.32)
Submitted January 16, 2009

Based on the statements made by the President of the company during the bio-tech conference conference in San Francisco, the FDA advised the company that they could use the data base on the one million patients already on Byetta, to meet the criteria… More

0 Comments | Reply | Report this Post

cubanrafter (< 20)
Submitted September 04, 2008

People are focusing on Pancreatitis.
The real issue is competition. Byetta is an adjunt therapy in uncontrolled patients. Now we have Januvia, who pretty much does the same thing, is oral and cheaper than Byetta. People do not like needles,… More

3 Comments | Reply | Report this Post
AMLN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about AMLN.

Recs

0
Member Avatar LimoDriver1971 (94.91) Submitted: 10/29/2009 4:00:20 PM : Outperform Start Price: $11.41 AMLN Score: +5.00

If this health care thing gets off the ground these pharmeceuticals that are producing and researching weight loss and related drugs are going to skyrocket.

Obesity and being over-weight will be a fineable offence - mark my words.

Doctors will have to prove that their patients are getting more healthy or be fined and given probationary periods.

I know I know - sounds Draconian and conspiracist - but you'll see.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar topsecret09 (45.57) Submitted: 9/20/2009 4:49:34 PM : Underperform Start Price: $13.10 AMLN Score: +9.03

I love the biotechs,but there Is heavy insider selling here... TS

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar SmallPimpin (98.78) Submitted: 9/1/2009 5:15:29 PM : Outperform Start Price: $12.49 AMLN Score: -11.26

Mmm...pharmaceuticals...

Report this Post 0 Comments | Reply | Permalink
View All 83 Pitches »

Leaderboard

Find the members with the highest scoring picks in AMLN.

Score Leader

Paradime

Paradime (98.80) Score: +85.69

The Score Leader is the member with the highest score across all their picks in AMLN.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
teamtec 84.19 11/24/2008 Outperform 1Y $6.09 +98.19% +33.82% +64.37
embodiedheart 97.11 12/2/2008 Outperform 5Y $6.26 +92.81% +29.39% +63.42
MudgieBoy 63.15 8/28/2006 Underperform 1Y $45.15 -73.27% -11.92% +61.34 1 Comment
massoudb 94.73 9/20/2006 Underperform 3W $44.36 -72.79% -14.02% +58.77
Gr8Vette 77.08 9/15/2006 Underperform 5Y $44.75 -73.03% -14.28% +58.75 1 Comment
ajsiegel 98.64 12/3/2008 Outperform 1Y $6.35 +89.97% +32.20% +57.77
rayinla < 20 9/27/2006 Underperform 1Y $43.96 -72.54% -14.77% +57.77 2 Comments
ina1fool < 20 9/27/2006 Underperform 3W $43.96 -72.54% -14.77% +57.77
gunny69 24.12 10/19/2006 Underperform 1Y $46.65 -74.13% -16.63% +57.50
EngelvonChemie 43.25 3/14/2007 Underperform 1Y $38.15 -68.36% -17.86% +50.50
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackCanaccord 84.17 1/28/2009 Underperform NS $10.80 +11.76% +26.19% +14.43
TrackJimCramer < 20 10/23/2008 Underperform 3W $11.34 +6.44% +19.87% +13.44
TrackLazardCapit < 20 9/2/2008 Outperform NS $22.40 -46.12% -15.05% -31.07
TrackSoleil 83.54 8/27/2008 Underperform NS $23.81 -49.31% -13.34% +35.97
TrackIcahn 27.08 5/29/2008 Outperform 1Y $31.68 -61.90% -20.09% -41.81 5 Comments
TrackBMOCapital 86.09 4/22/2008 Underperform NS $27.41 -55.96% -19.53% +36.44
TrackCanaccord 84.17 2/12/2008 Underperform NS $30.04 -45.24% -21.64% +23.60 10/7/2008 @ $16.45
TrackRWBaird 85.02 1/15/2008 Outperform NS $35.50 -37.38% -8.56% -28.82 8/27/2008 @ $22.23
TrackZacks 69.52 12/13/2007 Underperform 3M $38.87 -65.73% -33.71% +32.02 10/20/2008 @ $13.32 1 Comment
TrackLehmanBros 76.60 11/1/2007 Underperform NS $44.00 -28.98% -9.36% +19.62 5/28/2008 @ $31.25
TrackEdwardOwens 98.26 9/30/2007 Outperform NS $50.00 -75.86% -26.44% -49.42 2 Comments
TrackJefferies 75.83 9/26/2007 Outperform NS $49.99 -45.69% -10.14% -35.55 6/9/2008 @ $27.15
TrackZacks 69.52 9/11/2007 Underperform 3M $48.72 -6.36% +1.48% +7.84 10/19/2007 @ $45.62 1 Comment
TrackLazardCapit < 20 9/10/2007 Outperform NS $49.24 -48.80% -8.11% -40.69 3/3/2008 @ $25.21
TrackJimCramer < 20 7/30/2007 Outperform 3W $47.15 -75.95% -36.81% -39.14 10/23/2008 @ $11.34
TrackStanfordRes 80.42 7/24/2007 Outperform NS $44.08 -34.87% -15.19% -19.68 8/19/2008 @ $28.71
TrackGaryBSmith 41.83 5/25/2007 Outperform 3W $44.91 -73.12% -25.33% -47.79
TrackWRHambrecht 59.03 3/13/2007 Outperform NS $38.19 -68.39% -19.05% -49.34
TrackLeerinkSwan 84.26 2/5/2007 Outperform NS $39.00 -77.26% -40.61% -36.64 4/7/2009 @ $8.87
TrackBroadpoint.AmTech 73.02 1/31/2007 Underperform NS $38.93 -69.00% -20.17% +48.83
TrackFBRCapitalM 75.98 1/31/2007 Outperform NS $39.05 -34.98% -10.47% -24.51 6/30/2008 @ $25.39
TrackLazardCapit < 20 8/11/2006 Underperform NS $42.31 -5.32% +14.98% +20.30 4/13/2007 @ $40.06
TrackJimCramer < 20 2/27/2006 Underperform 3W $43.97 +7.23% +13.48% +6.25 7/31/2007 @ $47.15

Featured Broker Partners